$INVX
Innovex International, Inc.

2024 Q2 Form 10-Q Financial Statement

#000095017024052065 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $120.3M $110.3M
YoY Change 34.3% 21.39%
Cost Of Revenue $83.23M $78.42M
YoY Change 26.66% 19.72%
Gross Profit $37.11M $31.88M
YoY Change 55.31% 25.69%
Gross Profit Margin 30.84% 28.9%
Selling, General & Admin $29.77M $29.99M
YoY Change 28.06% 32.79%
% of Gross Profit 80.22% 94.08%
Research & Development $3.588M $3.738M
YoY Change 12.05% 9.97%
% of Gross Profit 9.67% 11.73%
Depreciation & Amortization $8.007M $8.432M
YoY Change 13.59% 22.4%
% of Gross Profit 21.57% 26.45%
Operating Expenses $29.77M $29.99M
YoY Change 12.56% 32.79%
Operating Profit -$4.666M -$18.80M
YoY Change 82.69% -689.77%
Interest Expense -$4.618M $4.091M
YoY Change -168.0% 5013.75%
% of Operating Profit
Other Income/Expense, Net $133.0K
YoY Change
Pretax Income -$2.613M -$16.61M
YoY Change -146.79% -379.8%
Income Tax -$801.0K $3.378M
% Of Pretax Income
Net Earnings -$1.812M -$19.98M
YoY Change -152.02% -964.73%
Net Earnings / Revenue -1.51% -18.12%
Basic Earnings Per Share -$0.05 -$0.58
Diluted Earnings Per Share -$0.05 -$0.58
COMMON SHARES
Basic Shares Outstanding 34.42M 34.41M
Diluted Shares Outstanding 34.44M 34.42M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $185.6M $202.2M
YoY Change -27.29% -20.47%
Cash & Equivalents $185.6M $198.2M
Short-Term Investments $0.00 $4.016M
Other Short-Term Assets $8.006M $8.285M
YoY Change -86.82% -77.09%
Inventory $204.7M $209.2M
Prepaid Expenses $16.92M $13.13M
Receivables $154.2M $137.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $707.6M $715.1M
YoY Change -6.3% -4.91%
LONG-TERM ASSETS
Property, Plant & Equipment $211.1M $215.3M
YoY Change 10.05% 17.45%
Goodwill $16.10M $16.30M
YoY Change
Intangibles $38.85M $40.25M
YoY Change 76.1% 77.37%
Long-Term Investments
YoY Change
Other Assets $7.497M $8.064M
YoY Change -29.35% 31.46%
Total Long-Term Assets $300.6M $305.9M
YoY Change 33.89% 36.99%
TOTAL ASSETS
Total Short-Term Assets $707.6M $715.1M
Total Long-Term Assets $300.6M $305.9M
Total Assets $1.008B $1.021B
YoY Change 2.91% 4.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $60.83M $62.91M
YoY Change 11.79% 33.24%
Accrued Expenses $54.35M $56.75M
YoY Change 135.86% 144.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $126.4M $133.6M
YoY Change 43.47% 60.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.599M $4.852M
YoY Change -39.65% 206.89%
Total Long-Term Liabilities $4.599M $4.852M
YoY Change -39.65% 206.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $126.4M $133.6M
Total Long-Term Liabilities $4.599M $4.852M
Total Liabilities $155.6M $163.7M
YoY Change 55.23% 72.25%
SHAREHOLDERS EQUITY
Retained Earnings $929.0M $930.8M
YoY Change -2.82% -2.54%
Common Stock $106.7M $103.4M
YoY Change 11.27% 10.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $852.5M $857.4M
YoY Change
Total Liabilities & Shareholders Equity $1.008B $1.021B
YoY Change 2.91% 4.68%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$1.812M -$19.98M
YoY Change -152.02% -964.73%
Depreciation, Depletion And Amortization $8.007M $8.432M
YoY Change 13.59% 22.4%
Cash From Operating Activities -$9.304M -$4.104M
YoY Change -182.47% -92.24%
INVESTING ACTIVITIES
Capital Expenditures $6.156M $4.757M
YoY Change -39.57% -12.3%
Acquisitions
YoY Change
Other Investing Activities $4.148M $22.27M
YoY Change 357.84% -22.61%
Cash From Investing Activities -$2.008M $17.51M
YoY Change -78.36% -25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -178.0K -297.0K
YoY Change 1518.18% 2600.0%
NET CHANGE
Cash From Operating Activities -9.304M -4.104M
Cash From Investing Activities -2.008M 17.51M
Cash From Financing Activities -178.0K -297.0K
Net Change In Cash -11.49M 10.90M
YoY Change -677.39% -137.0%
FREE CASH FLOW
Cash From Operating Activities -$9.304M -$4.104M
Capital Expenditures $6.156M $4.757M
Free Cash Flow -$15.46M -$8.861M
YoY Change -1511.87% -84.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001042893
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Address Country
EntityAddressCountry
US
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P0Y
CY2024Q1 us-gaap Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration
RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://www.dril-quip.com/20240331#RestructuringAndOtherCharges
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-13439
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
DRIL-QUIP, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-2162088
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2050 West Sam Houston Parkway S.
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1100
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77042
CY2024Q1 dei City Area Code
CityAreaCode
713
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
939-7711
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2024Q1 dei Trading Symbol
TradingSymbol
DRQ
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34420419
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
198197000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187323000
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
4103000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
4077000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
4016000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
25908000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
137135000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
135569000
CY2024Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
139610000
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
148429000
CY2024Q1 us-gaap Inventory Net
InventoryNet
209160000
CY2023Q4 us-gaap Inventory Net
InventoryNet
194593000
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13126000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
14119000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
8285000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9699000
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1513000
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2024Q1 us-gaap Assets Current
AssetsCurrent
715145000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
719717000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16356000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16343000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
215264000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
217631000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9663000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8989000
CY2024Q1 us-gaap Goodwill
Goodwill
16288000
CY2023Q4 us-gaap Goodwill
Goodwill
16654000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40247000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
41941000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8064000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6906000
CY2024Q1 us-gaap Assets
Assets
1021027000
CY2023Q4 us-gaap Assets
Assets
1028181000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
62907000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
60160000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7064000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5942000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6839000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7583000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14026000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14035000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2300000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2118000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
40420000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
27865000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
133556000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
117703000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10330000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10564000
CY2024Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
385000
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
346000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14541000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14554000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4852000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3754000
CY2024Q1 us-gaap Liabilities
Liabilities
163664000
CY2023Q4 us-gaap Liabilities
Liabilities
146921000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34419768
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34419768
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34386577
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34386577
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
343000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
343000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
103025000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
100289000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
930789000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
950719000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-176794000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-170091000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
857363000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
881260000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1021027000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1028181000
CY2024Q1 us-gaap Revenues
Revenues
110297000
CY2023Q1 us-gaap Revenues
Revenues
90865000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
78419000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
65502000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29991000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22585000
CY2024Q1 drq Engineering And Product Development
EngineeringAndProductDevelopment
3738000
CY2023Q1 drq Engineering And Product Development
EngineeringAndProductDevelopment
3399000
CY2024Q1 drq Restructuring And Other Charges
RestructuringAndOtherCharges
0
CY2023Q1 drq Restructuring And Other Charges
RestructuringAndOtherCharges
1718000
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
200000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
6647000
CY2024Q1 drq Acqusition Costs
AcqusitionCosts
19046000
CY2023Q1 drq Acqusition Costs
AcqusitionCosts
0
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1895000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1120000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
129099000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
87677000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18802000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3188000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2196000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2747000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16606000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5935000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3378000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3624000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-19984000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2311000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34417000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34128000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34417000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34489000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-19984000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2311000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6649000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
574000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26633000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2885000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-19984000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2311000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8432000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6889000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2788000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2577000
CY2024Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
683000
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
200000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
6647000
CY2024Q1 drq Business Acqusition Cost Under Operating Activities
BusinessAcqusitionCostUnderOperatingActivities
18087000
CY2023Q1 drq Business Acqusition Cost Under Operating Activities
BusinessAcqusitionCostUnderOperatingActivities
0
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1997000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-211000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
937000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39531000
CY2024Q1 drq Increase Decrease In Unbilled Receivable
IncreaseDecreaseInUnbilledReceivable
-3973000
CY2023Q1 drq Increase Decrease In Unbilled Receivable
IncreaseDecreaseInUnbilledReceivable
6376000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13152000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4758000
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1186000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1335000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
124000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9192000
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-52000
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4104000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52920000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4757000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5424000
CY2024Q1 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
375000
CY2023Q1 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
15460000
CY2024Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2023Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
9081000
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
21892000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
22392000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17510000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23347000
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-297000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-11000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-297000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2209000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10900000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29461000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191400000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
264804000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202300000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
235343000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
881260000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-6649000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-19984000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26633000
CY2024Q1 drq Shares With Held For Payment Of Employee Payroll Taxes
SharesWithHeldForPaymentOfEmployeePayrollTaxes
-52000
CY2024Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2788000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
857363000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
872352000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
574000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2311000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2885000
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2577000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
877814000
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:2.4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We reclassified approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of accrued professional fees for the year ended December 31, 2023, from accounts payable to other accrued liabilities to conform to our current year presentation. These reclassifications to the prior period were made to conform to the current period presentation and did not have an impact on our consolidated statements of income (loss), consolidated balance sheets, consolidated statements of comprehensive income (loss), consolidated statements of stockholders’ equity and consolidated statements of cash flows.</span></p>
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
5500000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:2.4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. Some of the Company’s more significant estimates are those affected by critical accounting policies for revenue recognition and asset recoverability tests and inventories</span>
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4100000
CY2024Q1 drq Amount To Maintain Cash Collateral Account For Letters Of Credit
AmountToMaintainCashCollateralAccountForLettersOfCredit
the outstanding letters of credit plus 5% at all times
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1208000
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34417000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34128000
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
361000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34417000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34489000
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1182000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1208000
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1182000
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1208000
CY2024Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2024Q1 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0
CY2023Q1 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0
CY2024Q1 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-26000
CY2023Q1 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
0
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1182000
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
148429000
CY2024Q1 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
107633000
CY2024Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
116452000
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
139610000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
56000000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.922
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.078
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
36428000
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
34950000
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
33302000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
33911000
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
139430000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
125732000
CY2024Q1 us-gaap Inventory Net
InventoryNet
209160000
CY2023Q4 us-gaap Inventory Net
InventoryNet
194593000
CY2024Q1 drq Reduction In Raw Materials By Reserve
ReductionInRawMaterialsByReserve
-6400000
CY2024Q1 drq Reduction In Work In Progress By Reserve
ReductionInWorkInProgressByReserve
-3500000
CY2024Q1 drq Reduction In Finished Goods By Reserve
ReductionInFinishedGoodsByReserve
-58300000
CY2023Q4 drq Reduction In Raw Materials By Reserve
ReductionInRawMaterialsByReserve
-8300000
CY2023Q4 drq Reduction In Work In Progress By Reserve
ReductionInWorkInProgressByReserve
-2700000
CY2023Q4 drq Reduction In Finished Goods By Reserve
ReductionInFinishedGoodsByReserve
-55200000
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
630000
CY2024Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0
CY2024Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-600000
CY2024Q1 drq Accrued Restructuring And Other Charges
AccruedRestructuringAndOtherCharges
-30000
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2023Q4 us-gaap Goodwill
Goodwill
16700000
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-400000
CY2024Q1 us-gaap Goodwill
Goodwill
16300000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
62313000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21564000
CY2024Q1 drq Finite Lived Intangible Assets Accumulated Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyTranslationGainLoss
-502000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40247000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
62231000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20269000
CY2023Q4 drq Finite Lived Intangible Assets Accumulated Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyTranslationGainLoss
-21000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
41941000
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q1 us-gaap Revenues
Revenues
110297000
CY2023Q1 us-gaap Revenues
Revenues
90865000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8432000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6889000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18802000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3188000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.203
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.611
CY2024Q1 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
1800000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-052065-index-headers.html Edgar Link pending
0000950170-24-052065-index.html Edgar Link pending
0000950170-24-052065.txt Edgar Link pending
0000950170-24-052065-xbrl.zip Edgar Link pending
drq-20240331.htm Edgar Link pending
drq-20240331.xsd Edgar Link pending
drq-ex31_1.htm Edgar Link pending
drq-ex31_2.htm Edgar Link pending
drq-ex32_1.htm Edgar Link pending
drq-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
drq-20240331_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable